BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220223T140000
DTEND;TZID=Europe/London:20220223T150000
DTSTAMP:20260408T062048
CREATED:20211013T074941Z
LAST-MODIFIED:20211013T074941Z
UID:18812-1645624800-1645628400@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Defining decentralised trials!
DESCRIPTION:                                                        \n  \n  \n \n \n\n\n\n\nJoin us for the next in the series of our Clinical Trial Special Interest Groups with Afortiori Development\, at this webinar “Defining decentralised trials! What actually defines a decentralised trial and how do they work in reality?”. \nThis webinar will focus on what it means to run a ‘decentralised trial’ in the real world! Hear from our panel of experts as they discuss key aspects of what it means to actually run a decentralised trial and how or if they can work for your study and product. Our speakers will discuss various tools and methodologies and then a discussion will follow that examines the importance of the right approach overall as the defining factor for study success. \nThis free-to-attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the SoLSTICE programme\, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all. \nDURATION: 1 hour \nSpeaker Profiles:  \n\nChaired by: Dr Nicola Wall\, Chief Executive Officer\, Afortiori Development\nNicola co-founded Afortiori Development after a long career in clinical research within a variety of roles.  Nicola has extensive experience and a proven track record in global clinical trial management\, quality assurance and process management in the healthcare industry. Afortiori have built an impressive global team of clinical trial specialists\, clinicians and biostatisticians with experience in adult\, paediatric and neonatal clinical research\, and both primary and secondary healthcare settings. \n\nCheryl Bailey\, Senior Global Project Manager\, Afortiori Development\nCheryl has worked in numerous roles in the clinical research industry for over 11 years and is the Senior Global Clinical Project Leader at Afortiori\, responsible for the management and delivery of clinical trial activities within the company. She has gained an extensive range of key skills including project management\, ethics and regulatory\, monitoring\, financial management\, budgets\, protocol writing\, skills training\, quality management and laboratory experience. Cheryl has had a varied range of therapeutic experience:– mental health disorders\, diabetes\, Alzheimer’s and MCI\, renal disease\, sickle cell disease\, healthy population studies\, medical devices\, dermatitis and psoriasis. She has managed a wide range of studies across various phases of research both in NHS settings and in CRO/CRF settings\, allowing for the development of a sound knowledge base\, an understanding of necessary operational processes and the skills to drive clinical trials forward. \n\nTim Davies\, Business Development Manager\, The Medical Research Network\nWith over 25 years in research and development with large pharma and over 8 years decentralised clinical trial services for speciality\, orphan and biodiversity medicines especially in the provision of specialised decentralised Nursing. \n\nWessam Sonbol\, Co-Founder & CEO\, Delve Health\nA proven biopharmaceuticals and healthcare solutions strategist focusing on life science process improvement\, Wessam has nearly 20 years of experience in Phase I-IV\, IDE and 510(K) clinical research and healthcare business operations. He’s successfully managed a data\nmanagement organisation and worked with Fortune 500 companies such as Medtronic\, Abbott Vascular and J&J. Through breakthrough strategies\, Wessam helps achieve notable results in improving clinical trial outcomes.
URL:https://staging.medilinkmidlands.com/event/webinar-defining-decentralised-trials/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/CB-Headshot-scaled.jpeg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR